Seminario INGEBI

Immune Cells Redirecting Therapies in Multiple Myeloma

Lunes 13 septiembre 2021

Dr. Ricardo Attar

Vice President, Oncology Translational Research, Janssen

Ricardo Attar is currently the head of Oncology Translational Research (TR), including the Hematologic Malignancies, Lung Cancer, Prostate Cancer and Immuno-Oncology TR teams, as well as the Operations, Laboratory, and Computational Biology TR teams. The Oncology TR group is responsible for all clinical biomarker and translational medicine strategies for compounds in development within the Oncology Therapeutic Area (TA) pipeline. The Oncology TR team will also continue to advance prevention and disease interception strategies across oncology.